Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma. (Q51013344)

27 March 2018

title

Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma. (English)

1 reference

27 March 2018

author name string

Eishiro Mizukoshi

1

1 reference

27 March 2018

Yasunari Nakamoto

2

1 reference

27 March 2018

Kuniaki Arai

3

1 reference

27 March 2018

Tatsuya Yamashita

4

1 reference

27 March 2018

Akito Sakai

5

1 reference

27 March 2018

Yoshio Sakai

6

1 reference

27 March 2018

Takashi Kagaya

7

1 reference

27 March 2018

Taro Yamashita

8

1 reference

27 March 2018

Masao Honda

9

1 reference

27 March 2018

Shuichi Kaneko

10

1 reference

27 March 2018

language of work or name

English

0 references

publication date

1 April 2011

1 reference

27 March 2018

published in

Hepatology

1 reference

27 March 2018

volume

53

1 reference

27 March 2018

issue

4

1 reference

27 March 2018

page(s)

1206-1216

1 reference

27 March 2018

Estimating the world cancer burden: Globocan 2000.

cites work

1 reference

Loco-regional treatment of hepatocellular carcinoma

21 January 2018

1 reference

Recognition of the Lck tyrosine kinase as a tumor antigen by cytotoxic T lymphocytes of cancer patients with distant metastases

21 January 2018

1 reference

A MAGE-1-encoded HLA-A24-binding synthetic peptide induces specific anti-tumor cytotoxic T lymphocytes

21 January 2018

1 reference

Identification of a SART-1-derived peptide capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes

21 January 2018

1 reference

Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL

21 January 2018

1 reference

Mapping the HLA-A24-restricted T-cell epitope peptide from a tumour-associated antigen HER2 / neu: possible immunotherapy for colorectal carcinomas

21 January 2018

1 reference

Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53.

21 January 2018

1 reference

Identification of alpha-fetoprotein-derived peptides recognized by cytotoxic T lymphocytes in HLA-A24+ patients with hepatocellular carcinoma

21 January 2018

1 reference

Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma

21 January 2018

1 reference

Current developments in cancer vaccines and cellular immunotherapy

21 January 2018

1 reference

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

Personalized peptide vaccines: a new therapeutic modality for cancer

21 January 2018

1 reference

Immune therapy for cancer

21 January 2018

1 reference

Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study.

21 January 2018

1 reference

A novel cytotoxic T-cell epitope presented by HLA-A24 molecule in hepatitis C virus infection

21 January 2018

1 reference

Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8(+) T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay.

21 January 2018

1 reference

A newly identified MAGE-3-derived epitope recognized by HLA-A24-restricted cytotoxic T lymphocytes

21 January 2018

1 reference

Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

21 January 2018

1 reference

Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses.

21 January 2018

1 reference

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

21 January 2018

1 reference

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies

21 January 2018

1 reference

Ex vivo characterization of tumor-derived melanoma antigen encoding gene-specific CD8+cells in patients with hepatocellular carcinoma

21 January 2018

1 reference

Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

Immunohistologic study on the expressions of alpha-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma.

21 January 2018

1 reference

TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer

21 January 2018

1 reference

Multiple roles for CD4+ T cells in anti-tumor immune responses

21 January 2018

1 reference

Trends in primary liver cancer

21 January 2018

1 reference

7 January 2021

Intrahepatic distant recurrence after radiofrequency ablation for a single small hepatocellular carcinoma: risk factors and patterns

1 reference

7 January 2021

Identification of p53 peptides recognized by CD8(+) T lymphocytes from patients with bladder cancer

1 reference

7 January 2021

A Phase I/II Trial Testing Immunization of Hepatocellular Carcinoma Patients with Dendritic Cells Pulsed with Four -Fetoprotein Peptides

1 reference

7 January 2021

Dynamic CT densitometry of hepatic tumors

1 reference

7 January 2021

Unmasking of alpha-fetoprotein-specific CD4(+) T cell responses in hepatocellular carcinoma patients undergoing embolization

1 reference

7 January 2021

Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.24149

1 reference

27 March 2018

PubMed ID

21480325

1 reference

27 March 2018